Subclinical Hypothyroidism with Borderline Labs

May 20, 2026
Share this post

Clinical History

45-year-old female with six months of fatigue and mild weight gain. TSH 6.8 (ref 0.4–4.0), free T4 normal at 1.1. TPO antibodies positive. No goiter, not pregnant, no pregnancy plans.

Clinical Question

TSH is only mildly elevated and free T4 is normal. Would you treat, or watch? Does the positive TPO change anything?

Specialist Guidance

The TPO antibodies are the deciding factor. With TSH between 5 and 10, treatment is a judgment call in most patients. But positive TPO antibodies mean she’s progressing toward overt hypothyroidism at roughly 4–5% per year. Combined with symptoms and TSH pushing toward 7, I’d start a trial of weight-based levothyroxine dosing. Recheck TSH in 2–3 months, aiming for 1–3.

Key thing to watch: if her TSH normalizes on appropriate weight-based dosing and the fatigue doesn’t improve after 6–8 weeks, it’s probably not the thyroid. At that point, stop the levothyroxine and just monitor TSH. Don’t keep pushing the dose chasing symptoms. Over-treating subclinical hypothyroidism creates its own problems, particularly bone density and afib risk in women.

If you had chosen to observe instead, recheck TSH every 6–12 months given the antibodies. No endo referral needed.

Outcome

Started weight-based levothyroxine. TSH normalized to 2.4 at 3-month recheck. Fatigue improved modestly. Managed entirely in primary care. No referral required. Annual TSH monitoring.

Introduce specialty expertise earlier in care.

See how TeleCurbMD fits within your care model.